当前位置:首页 - 行情中心 - 康泰生物(300601) - 财务分析

康泰生物

(300601)

  

流通市值:207.94亿  总市值:265.38亿
流通股本:8.75亿   总股本:11.17亿

康泰生物(300601)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润6.97亿元,每股收益0.62元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益957832.27万元,未分配利润233813.85万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产1472333.42万元,负债514501.15万元。

利润表
报告期2023-09-302023-06-302023-03-312022-12-31
营业总收入2,464,464,778.621,730,568,886.34748,383,301.393,157,401,754.79
营业总成本1,732,477,412.921,180,899,409.01502,644,829.282,617,680,291.59
营业利润768,749,273.17566,356,417.92244,347,202.88-317,570,999.76
利润总额765,002,501.6563,760,501.86241,818,059.26-338,246,462.39
净利润697,050,864.48510,431,517.35205,462,820.25-132,707,859.29
其他综合收益----
综合收益总额697,050,864.48510,431,517.35205,462,820.25-132,707,859.29
资产负债表
报告期2023-09-302023-06-302023-03-312022-12-31
流动资产合计5,429,005,148.745,431,093,463.755,118,815,788.675,174,850,130.69
非流动资产合计9,294,329,010.378,854,049,592.738,685,825,865.68,611,501,540.46
资产总计14,723,334,159.1114,285,143,056.4813,804,641,654.2713,786,351,671.15
流动负债合计2,524,566,186.212,379,661,833.822,203,444,033.282,339,812,000.87
非流动负债合计2,620,445,305.312,513,816,679.532,511,345,302.222,461,201,501.4
负债合计5,145,011,491.524,893,478,513.354,714,789,335.54,801,013,502.27
归属于母公司股东权益合计9,578,322,667.599,391,664,543.139,089,852,318.778,985,338,168.88
股东权益合计9,578,322,667.599,391,664,543.139,089,852,318.778,985,338,168.88
负债和股东权益合计14,723,334,159.1114,285,143,056.4813,804,641,654.2713,786,351,671.15
现金流量表
报告期2023-09-302023-06-302023-03-312022-12-31
经营活动现金流入小计2,300,307,228.261,430,890,027.37642,590,568.953,074,851,363.14
经营活动现金流出小计1,674,535,201.331,091,639,445.6513,994,084.362,529,155,411.61
经营活动产生的现金流量净额625,772,026.93339,250,581.77128,596,484.59545,695,951.53
投资活动现金流入小计758,358,499.81535,038,598.7434,545,231.52,234,088,360.53
投资活动现金流出小计1,139,568,195.24886,222,691.37396,844,586.714,840,392,357.63
投资活动产生的现金流量净额-381,209,695.43-351,184,092.6737,700,644.79-2,606,303,997.1
筹资活动现金流入小计194,662,14579,925,367.2839,453,723.51,279,261,889.06
筹资活动现金流出小计424,799,612.67309,893,713.18270,104,442.171,744,137,894.48
筹资活动产生的现金流量净额-230,137,467.67-229,968,345.9-230,650,718.67-464,876,005.42
汇率变动对现金及现金等价物的影响51,644.4261,260.07-380.24-1,662,784.23
现金及现金等价物净增加额14,476,508.25-241,840,596.73-64,353,969.53-2,527,146,835.22
期末现金及现金等价物余额1,008,585,794.05752,268,689.07929,755,316.27994,109,285.8
最新报告期:2024-03-10
研究机构分析师预测每股收益(元)更新日
2023年2024年2025年
中信建投证券刘若飞,贺菊颖0.800.921.152024-03-10
德邦证券陈铁林0.791.021.232024-03-08
中信建投刘若飞,贺菊颖0.830.901.132024-01-04
中信建投证券刘若飞,贺菊颖0.830.901.132024-01-04
TOP↑